Functional immune characterization of HIV-associated non-small-cell lung cancer.
作者信息
Pinato D J, Kythreotou A, Mauri F A, Suardi E, Allara E, Shiner R J, Akarca A U, Trivedi P, Gupta N, Dalla Pria A, Marafioti T, Oliveri P, Newsom-Davis T, Bower M
机构信息
Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK; National Centre for HIV Malignancies, Chelsea & Westminster Hospital, London, UK.
Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK.
出版信息
Ann Oncol. 2018 Jun 1;29(6):1486-1488. doi: 10.1093/annonc/mdy125.
Abstract
摘要
相似文献
1
Functional immune characterization of HIV-associated non-small-cell lung cancer.
Ann Oncol. 2018 Jun 1;29(6):1486-1488. doi: 10.1093/annonc/mdy125.
2
Increase of programmed death ligand 1 in non-small-cell lung cancers with chronic hepatitis B.
Ann Oncol. 2018 Feb 1;29(2):516-517. doi: 10.1093/annonc/mdx694.
3
High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer.
Cancer Immunol Immunother. 2018 Mar;67(3):495-505. doi: 10.1007/s00262-017-2103-y. Epub 2017 Dec 14.
4
Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach.
Clin Lung Cancer. 2017 Mar;18(2):220-233.e8. doi: 10.1016/j.cllc.2016.09.009. Epub 2016 Oct 5.
5
Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.
Arch Pathol Lab Med. 2017 Nov;141(11):1529-1532. doi: 10.5858/arpa.2017-0028-OA. Epub 2017 Aug 22.
6
Correlation Between Programmed Death Receptor-1 Expression in Tumor-Infiltrating Lymphocytes and Programmed Death Ligand-1 Expression in Non-Small Cell Lung Carcinoma.
Arch Pathol Lab Med. 2018 Nov;142(11):1388-1393. doi: 10.5858/arpa.2017-0516-OA. Epub 2018 Feb 12.
7
Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer.
Lung Cancer. 2019 Nov;137:56-63. doi: 10.1016/j.lungcan.2019.09.013. Epub 2019 Sep 16.
8
B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
Oncotarget. 2015 Feb 20;6(5):3452-61. doi: 10.18632/oncotarget.3097.
9
Variants in Epithelial-Mesenchymal Transition and Immune Checkpoint Genes Are Associated With Immune Cell Profiles and Predict Survival in Non-Small Cell Lung Cancer.
Arch Pathol Lab Med. 2020 Oct 1;144(10):1234-1244. doi: 10.5858/arpa.2019-0419-OA.
10
Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations.
J Thorac Oncol. 2018 Dec;13(12):1884-1896. doi: 10.1016/j.jtho.2018.09.012. Epub 2018 Sep 26.
引用本文的文献
1
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma.
JHEP Rep. 2023 Mar 22;5(7):100741. doi: 10.1016/j.jhepr.2023.100741. eCollection 2023 Jul.
2
Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities.
Vaccines (Basel). 2022 Oct 7;10(10):1673. doi: 10.3390/vaccines10101673.
3
Lymphocytes Infiltration and Expression of PD-1 and PD-L1 in Colorectal Cancer Between HIV-Infected and Non-HIV-Infected Patients: A Propensity Score Matched Cohort Study.
Front Oncol. 2022 Mar 2;12:827596. doi: 10.3389/fonc.2022.827596. eCollection 2022.
4
Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression.
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001519.
5
Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment.
Int J Mol Sci. 2020 Feb 26;21(5):1601. doi: 10.3390/ijms21051601.
6
Cancer immunotherapy of patients with HIV infection.
Clin Transl Oncol. 2019 Jun;21(6):713-720. doi: 10.1007/s12094-018-1981-6. Epub 2018 Nov 17.
本文引用的文献
1
Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer.
Ann Oncol. 2018 Feb 1;29(2):517-518. doi: 10.1093/annonc/mdx696.
2
Nonsmall cell lung cancer from HIV-infected patients expressed programmed cell death-ligand 1 with marked inflammatory infiltrates.
AIDS. 2018 Feb 20;32(4):461-468. doi: 10.1097/QAD.0000000000001713.
3
Classifying Cancers Based on T-cell Infiltration and PD-L1.
Cancer Res. 2015 Jun 1;75(11):2139-45. doi: 10.1158/0008-5472.CAN-15-0255.
4
Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy.
Clin Cancer Res. 2014 Oct 1;20(19):5064-74. doi: 10.1158/1078-0432.CCR-13-3271. Epub 2014 Apr 8.
5
HIV-related lung cancer in the era of highly active antiretroviral therapy.
AIDS. 2003 Feb 14;17(3):371-5. doi: 10.1097/00002030-200302140-00011.
Zotero 插件